Fungal Infections | Qnostics Molecular Controls
The treatment and management of patients with compromised immune systems has seen important developments in recent years. As a result the healthcare and management of immunocompromised patients has greatly improved. However, pathogen infection remains a significant contributor to morbidity and mortality in these patients.
A number of opportunistic parasitic pathogens are of concern in the management of immunocompromised patients including Candida spp. and Aspergillus spp.
Candida (Candida spp) Evaluation Panel
Pathogen – Candida albicans, Candida glabrata, Candida krusei
Matrix – Serum
Panel – 7 (High, Medium & Negative)
Stability – Single use Evaluation Panel designed to be used immediately minimising the risk of contamination
Shelf Life – Up to 2 years after date of manufacture
Regulatory Status – IVD & RUO
__________
Candida Evaluation Panel
Product code: CANEP | Pack size: 7×0.5 ml
Aspergillus (Aspergillus spp) Evaluation Panel
Pathogen – Aspergillus fumigatus, Aspergillus terreus
Matrix – Serum
Panel Members – 5 (High, Medium & Negative)
Stability – Single use Evaluation Panel designed to be used immediately minimising the risk of contamination
Shelf Life – Up to 2 years after date of manufacture
Regulatory Status – IVD & RUO
__________
Aspergillus Evaluation Panel
Product code: ASPEP | Pack size: 5×0.5 ml
Want to know more?
Contact us or visit our Qnostics page to learn more.
